Skip to content

Study · Measured the body's own peptide · 1994

1 result

Endocrine changes associated with a rapidly developing sodium appetite in rats.

Thunhorst RL, Morris M, Johnson AK

The American journal of physiology1 Nov 1994Cited by 31 (Europe PMC)

PMID7977842 (opens in a new tab)DOI10.1152/ajpregu.1994.267.5.r1168 (opens in a new tab)PepBankPUB-07977842
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In rats given furosemide plus low-dose captopril, plasma oxytocin did not increase, while plasma vasopressin did.

    In plain wordsIn rats given furosemide and low-dose captopril, the body's own oxytocin level in blood did not rise.

    Peptide
    Oxytocin
    Outcome
    No significant changePlasma oxytocin after furosemide plus captopril
    Study

    ratn: not reported in source

    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    Treatment with furosemide plus low-dose captopril increased plasma vasopressin but not plasma oxytocin.
    1 context sentence
    Summary · context
    To elucidate potential mechanisms for mediating this behavior, changes in plasma levels of key hormones involved in fluid intake and balance were characterized in rats subjected to this treatment protocol.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:53 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.